Retrospective study investigating efficacy of treatment of pan-drug resistant Acinetobacter baumannii (PDRAB) infection with combination regimen of meropenem, cefoperazone-sulbactam and minocycline in extensive burns patients

Trial Profile

Retrospective study investigating efficacy of treatment of pan-drug resistant Acinetobacter baumannii (PDRAB) infection with combination regimen of meropenem, cefoperazone-sulbactam and minocycline in extensive burns patients

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Dec 2015

At a glance

  • Drugs Cefoperazone/sulbactam (Primary) ; Meropenem (Primary) ; Minocycline (Primary)
  • Indications Acinetobacter infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top